Español
Research education

Sermorelin

Sermorelin's distinctive idea is to work through the body's GH-release pathway. Its clinical history and human hormone studies make it an interesting bridge between established endocrinology and newer recovery discussions.

Evidence snapshot

A 29-amino-acid GHRH analog that stimulates the pituitary. Historical uses focused on hormone testing and selected growth-deficiency settings; current wellness claims ask different questions.

Why it stands out

The attraction is engaging a hormone signal the body already uses. People are curious about sleep, recovery and body composition, but those goals deserve their own measured results instead of being inferred from GH alone.

How it may work

It stimulates the pituitary through the GHRH receptor rather than supplying growth hormone directly.

What studies found

A study of nightly GHRH(1–29) in healthy older men found increased nighttime GH release and improvement in two of six strength measures. The study did not find a corresponding rise in IGF-1, illustrating why different outcomes need to be reported separately.

What the evidence means

Human activity is established, but the adult studies are small and older. They provide leads for further research, not a reliable prediction of muscle gain, improved sleep or rejuvenation for every adult.

Safety and limitations

Local injection reactions and flushing have been reported. Endocrine conditions, glucose control and other hormone treatments matter when evaluating GH stimulation. A physiological pathway can still produce unwanted effects.

Current status

Sermorelin has a historical regulatory record, but research-market vials are not automatically approved prescription products. The 2027 WADA list names sermorelin as a growth-hormone releasing factor in class S2.2.4, prohibited at all times in tested sport.

Common questions

Is sermorelin growth hormone? No. It sends a release signal to the pituitary. The response depends on that system's ability to respond, which is why diagnosis and measured outcomes matter.

Personal accounts, not clinical results

A person describing several months of prescribed sermorelin reports better sleep and energy. Other linked discussions describe little sleep improvement. These contrasting experiences make sleep continuity and daytime function more useful to track than expecting a fixed result.

Open interactive profile →

Research sources

  1. GHRH(1-29) · six-week study in older men, 1997
  2. Sermorelin clinical review
  3. WADA 2027 Prohibited List · effective 1 Jan 2027